Health

Mallinckrodt and Terumo BCT Announce UVADEX® (Methoxsalen) Approved in Australia for use with the THERAKOS® CELLEX® Photopheresis System for the Treatment of Chronic Graft Versus Host Disease (cGvHD) and Skin Manifestations of Cutaneous T-Cell Lymphoma (CTCL) in Adults

SYDNEY, Nov. 1, 2019 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, and Terumo BCT, a global leader in blood component, therapeutic apheresis and cellular technologies, today announced that UVADEX®  (methoxsalen) has received regulatory approval inAustralia by th...

2019-11-01 04:35 6546

Icon Group Expands Cancer Care Capabilities with Purchase of Varian Adaptive Therapy Solution

PALO ALTO, California, Oct. 31, 2019 /PRNewswire/ -- Icon Group, Australia's largest dedicated provider of cancer care, with a growing reach intoNew Zealand andAsia, has made a purchase order to further improve the quality of cancer care treatment across its international network. The order inc...

2019-10-31 04:05 6626

Happiness Biotech Group Limited Announces Closing of US$11 Million Firm Commitment Initial Public Offering

NANPING, China, Oct. 30, 2019 /PRNewswire/ -- Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), an innovativeChina-based nutraceutical and dietary supplements producer, announced today the closing of previously announced a U.S. underwritten initial public offering ("Offering") of 2...

2019-10-31 02:30 6564

Presagen's AI Open Projects for clinics enables scalable unbiased AI medical products to be built from globally diverse datasets

SAN MATEO, Calif. and ADELAIDE, Australia, Oct. 30, 2019 /PRNewswire/ -- Presagen has launched a new AI product for clinics at the HLTH conference inLas Vegas, aimed at revolutionizing the way AI is applied to healthcare.   Presagen's AI Open Projects in an online platform that ...

2019-10-30 22:17 1096

Vivo Capital Closes $1.43 Billion Fund IX to Invest in Healthcare and Life Science Companies

PALO ALTO, California, Oct. 30, 2019 /PRNewswire/ -- Vivo Capital, a healthcare investment firm, announced the final closing of Vivo Capital Fund IX, L.P. (the "Fund") at$1.43 billion in committed capital from a broad group of existing and new global institutional investors. The firm plans to use...

2019-10-30 21:15 1232

GC Pharma Reports Q3 2019 Results

YONGIN, South Korea, Oct. 30, 2019 /PRNewswire/ -- GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, today announced unaudited results for the three months endedSeptember 30, 2019. Key Figures Q3 2019(1) Growth(1) Total revenues K...

2019-10-30 21:00 6328

Spectrum Therapeutics and Tree of Knowledge Announce Partnership to Educate and Support Healthcare Professionals

SMITHS FALLS, Ontario, Oct. 30, 2019 /PRNewswire/ -- Spectrum Therapeutics, the medical division of Canopy Growth Corporation ("Canopy Growth") (TSX:WEED) (NYSE: CGC) is pleased to announce that it has partnered with Tree of Knowledge International Corp. ("Tree of Knowledge") (CSE: TOKI) (OTC: TO...

2019-10-30 20:00 4463

World Pancreatic Cancer Day Campaign Launches to Raise Awareness of the Risks and Symptoms of the World's Toughest Cancer

More than 80 organizations from 30 countries to advocate for early diagnosis of pancreatic cancer onThursday, Nov. 21 MANHATTAN BEACH, California, Oct. 30, 2019 /PRNewswire/ -- Pancreatic cancer has the lowest survival rate among all major cancers because few people know the risks and symptoms a...

2019-10-30 05:47 852

WAT Medical will be returning to 2019 MEDICA to exhibit their innovative wearable technologies

VANCOUVER, British Columbia, Oct. 29, 2019 /PRNewswire/ -- From November 18-21, 2019, WAT Medical will be showcasing their EmeTerm, the anti-vomiting wristband, and HeadaTerm, the anti-migraine head patch, at one of the largest healthcare trade shows, MEDICA, inDusseldorf, Germany at Stand Hall 1...

2019-10-29 21:00 1642

Volition announces $500,000 in Non-Dilutive Funding for Volition Veterinary and issues Video

AUSTIN, Texas, Oct. 29, 2019 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced the confirmation of a further$500,000 non-dilutive funding in the form of a loan from the Texas A&M SOFINEX funding agency of the Walloon Region to support the development of its sub...

2019-10-29 20:30 6306

Herbalife Nutrition Foundation Opens Six New Casa Herbalife Programs in Asia Pacific, Supporting Nutrition Programs for Children in Need

HONG KONG, Oct. 29, 2019 /PRNewswire/ -- Continuing its mission to improve communities around the world, the Herbalife Nutrition Foundation (HNF) has announced the addition of 29 new Casa Herbalife Nutrition programs in 20 countries around the globe. Of the 29 new programs, six are  based in theA...

2019-10-29 15:00 2145

Arena Pharmaceuticals Announces First Subject Dosed in ADVISE Phase 2 Trial Evaluating Etrasimod in Atopic Dermatitis

- ADVISE clinical trial initiated and enrollment progressing - Evaluating patients with the clinical diagnosis of moderate-to-severe atopic dermatitis - Significant unmet need for an oral therapy in atopic dermatitis SAN DIEGO, Oct. 28, 2019 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ...

2019-10-28 20:30 3156

HistoIndex Announces Global Partnerships To Expand AI-Based Digital Pathology Platform As A Drug Discovery Tool In Preclinical Studies For Nonalcoholic Steatohepatitis (NASH)

SINGAPORE, Oct. 26, 2019 /PRNewswire/ -- HistoIndex announces the expansion of its AI-based digital pathology platform towards large-scale NASH preclinical programs for pharmaceutical and biotech companies to achieve quantifiable and reproducible...

2019-10-26 19:00 1899

Adagene Presents Its Lead Antibody Program, ADG106, at International Conferences

SAN FRANCISCO and SUZHOU, China, Oct. 26, 2019 /PRNewswire/ -- Adagene, Inc., a clinical stage biotech company with innovative antibody discovery and engineering technologies, announced that it is presenting its lead program at international conferences.  During the Festival of Biologics confere...

2019-10-26 18:01 1979

Wuyi 13th hot Spring Festival and the 10th international health expo opened on 25th

WUYI, China, Oct. 26, 2019 /PRNewswire/ -- A tree that grows old stays green. The news from Fusion media center in Wuyi onOctober 25, the 13th hot Spring Festival and the 10th international health expo opened in Wuyi county. 33 grand activities and thousands of health products attracted nearly 10...

2019-10-26 17:05 1483

Texas A&M University Takes A 12.5% Equity Stake in Volition Veterinary Diagnostics Development LLC

AUSTIN, Texas, Oct. 25, 2019 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") announced today that it (through its subsidiaries) has executed binding agreements contemplated by the previously announced Memorandum of Understanding withTexas A&M University ("Texas A&M"), a memb...

2019-10-26 00:00 8901

CHINA AID 2020 Will be Held in Shanghai From 11th-13th June, 2020

SHANGHAI, Oct. 25, 2019 /PRNewswire/ -- CHINA AID 2020 organized by the Shanghai Civil Affairs Bureau, the China Council for the Promotion of International Trade Shanghai and Shanghai Intex Exhibition will be held in Shanghai from 11th-13th June, 2020. As the most established and influential exh...

2019-10-26 00:00 1724

Happiness Biotech Group Limited Announces Pricing of US$11 Million Firm Commitment Initial Public Offering

NANPING, China, Oct. 25, 2019 /PRNewswire/ -- Happiness Biotech Group Limited (the "Company"), an innovativeChina-based nutraceutical and dietary supplements producer,announced today the pricing of a U.S. underwritten initial public offering ("Offering") of 2,000,000 ordinary shares at a price to...

2019-10-25 22:00 8898

111 to Announce Third Quarter 2019 Unaudited Financial Results on November 14, 2019

SHANGHAI, Oct. 25, 2019 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform inChina , today announced that it will report its unaudited financial results for the third quarter endedSeptember 30, 2019, before the open of U.S. ...

2019-10-25 20:00 5417

World first clinical trial commenced in alcohol use disorder

MELBOURNE, Australia, Oct. 24, 2019 /PRNewswire/ -- A medication currently used to treat insomnia may also be effective in preventing alcohol intake and relapse in alcohol use disorder, according to researchers at the Florey Institute of Neuroscience and Mental Health. A world-first clinical stu...

2019-10-24 12:01 1310